NASDAQ · Financial Statements
Mainz Biomed B.V. (MYNZ) Financial Statements
$3.59
NASDAQ: MYNZ
Market Cap $14.69M
Overview Financials Dividend
Mainz Biomed B.V. most recently reported annual revenue of $1.0M, a net loss of $16.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $1.0M $1.0M $1.0M $1.0M $1.0M Operating Profit $-10.0M $-26.0M $-27.0M $-19.0M $-13.0M Net Profit $-12.0M $-26.0M $-26.0M $-22.0M $-16.0M EPS $-1.67 $-1.87 $-1.62 $-22.36 $-2.70 Op Margin -1684.4% -4990.6% -2975.5% -2091.2% -2513.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $10.0M $20.0M $15.0M $13.0M $5.0M Total Liabilities $4.0M $6.0M $12.0M $7.0M $5.0M Cash $9.0M $17.0M $7.0M $6.0M $1.0M Borrowings $3.0M $3.0M $7.0M $3.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-3.0M $-15.0M $-22.0M $-17.0M $-11.0M Investing Cash Flow $1.0M $-1.0M $-4.0M $0 $-1.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $9.0M $8.0M $-10.0M $-1.0M $-5.0M Free Cash Flow $-3.0M $-15.0M $-24.0M $-17.0M $-11.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.03 EV / EBITDA -1.53 FCF Yield -35.08% Quick Ratio 2.11 Interest Coverage -39.06 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .